Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/28/2025

Expected Hemoglobin Decrease on Heparin Drip

Key Monitoring Principles

  • Serial hemoglobin/hematocrit measurements are recommended at least daily during unfractionated heparin (UFH) therapy to detect occult bleeding early, as suggested by the American Heart Association 1, 2, 3
  • Any clinically significant bleeding, recurrent symptoms, or hemodynamic instability should prompt immediate hemoglobin determination, according to the American College of Cardiology 1, 2, 3
  • The purpose of this monitoring is to detect bleeding complications, not because heparin causes an expected physiologic drop in hemoglobin, as stated by the American Heart Association 1, 2, 3

Common Pitfalls to Avoid

  • When hemoglobin decreases on heparin therapy, immediately assess for overt bleeding, hemodynamic instability, and need for aPTT check to ensure therapeutic anticoagulation, as recommended by the American College of Cardiology 1, 2, 3

Platelet Monitoring

  • Serial platelet counts are necessary to monitor for heparin-induced thrombocytopenia (HIT), with mild thrombocytopenia occurring in 10-20% of heparin patients and significant thrombocytopenia in 1-5%, according to the American Society of Hematology 1, 2
  • HIT typically appears after 4-14 days of therapy but can occur earlier in previously sensitized patients, as reported by the Anaesthesia society 4, 5, 6, 7

Clinical Algorithm for Hemoglobin Changes on Heparin

  • Baseline hemoglobin should be obtained before starting heparin, and daily monitoring of hemoglobin/hematocrit is recommended, as suggested by the American Heart Association 1, 2, 3
  • If hemoglobin drops, examine the patient for bleeding sources and check aPTT, according to the American College of Cardiology 1, 2, 3